Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe +7 more·2015·Nature Communications

DOI 10.1038/ncomms7744

Cited by (1,000)

Items 101–200 of 1,000

Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Elisabeth Heßmann, Steven A. Johnsen, Jens Thomas Siveke, Volker Ellenrieder · 2016 · Gut
Liquid Biopsies, Novel Approaches and Future Directions
Athanasios Armakolas, Maria Kotsari, John S. Koskinas · 2023 · Cancers
Surgical and molecular pathology of pancreatic neoplasms
Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, Lodewijk A.A. Brosens · 2016 · Diagnostic Pathology
Molecular subtypes in cancers of the gastrointestinal tract
Maarten F. Bijlsma, Anguraj Sadanandam, Patrick B. O. Tan, Louis Vermeulen · 2017 · Nature Reviews Gastroenterology & Hepatology
Precancerous neoplastic cells can move through the pancreatic ductal system
Makohon-Moore, Alvin P., Matsukuma, Karen, Zhang, Ming, Reiter, Johannes G., Gerold, Jeffrey M., Jiao, Yuchen, Sikkema, Lisa, Attiyeh, Marc A., Yachida, Shinichi, Sandone, Corinne et al. · 2018 · Nature
Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy
Teresa G. Krieger, Solange Le Blanc, Julia Jabs, Foo Wei Ten, Naveed Ishaque, Katharina Jechow, Olivia Debnath, Carl-Stephan Leonhardt, Anamika Giri, Roland Eils et al. · 2021 · Nature Communications
FOXM1: A small fox that makes more tracks for cancer progression and metastasis
Md Arafat Khan, Parvez Κhan, Aatiya Ahmad, Mahek Fatima, Mohd Wasim Nasser · 2023 · Seminars in Cancer Biology
Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm
Krushna Chandra Patra, Nabeel M. Bardeesy, Yusuke Mizukami · 2017 · Clinical and Translational Gastroenterology
Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, Elisa Giovannetti, Omidreza Firuzi · 2022 · Critical Reviews in Oncology/Hematology
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Elvira Pelosi, Germana Castelli, Ugo Testa · 2017 · Biomedicines
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, Rosanna Upstill‐Goddard, Ulla‐Maja Bailey, Ian Garner, Craig Nourse, Stephan B. Dreyer, Marc D. Jones, Kim Moran‐Jones et al. · 2020 · Cell Reports
How Schwann cells facilitate cancer progression in nerves
Sylvie Deborde, Richard J. Wong · 2017 · Cellular and Molecular Life Sciences
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Gemma van Duijneveldt, Michael D. W. Griffin, Tracy L. Putoczki · 2020 · Clinical Science
SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer
Australian Pancreatic Cancer Genome Initiative, Nathanial Lachlan Ewart Harris, Claire Vennin, James R. W. Conway, Kara L. Vine, Mark Pinese, Mark J. Cowley, R F Shearer, Morghan C. Lucas, David Herrmann et al. · 2017 · Oncogene
Elevated glypican‐1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
Haizhen Lu, Fangfei Niu, Fang Liu, Jiajia Gao, Yulin Sun, Xiaohang Zhao · 2017 · Cancer Medicine
TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer
Mengyu Tu, Lukas Klein, Elisa Espinet, Theodoros Georgomanolis, Florian Wegwitz, Xiaojuan Li, Laura Urbach, Adi Danieli‐Mackay, Stefan Küffer, Kamil Bojarczuk et al. · 2021 · Nature Cancer
Complete regression of advanced pancreatic ductal adenocarcinomas upon combined inhibition of EGFR and C-RAF
Blasco, María Teresa, Navas, Carolina, Martín-Serrano, Guillermo, Graña-Castro, Osvaldo, Lechuga, Carmen G., Martín-Díaz, Laura, Djurec, Magdolna, Li, Jing, Morales-Cacho, Lucia, Esteban-Burgos, Laura et al. · 2019 · Cancer Cell
Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes
Anna Melissa Schlitter, Angela Segler, Katja Steiger, Christoph W. Michalski, Carsten Jäger, Björn Konukiewitz, Nicole Pfarr, Volker Endris, Markus Bettstetter, Bo Kong et al. · 2017 · Scientific Reports
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage
Lukas Perkhofer, Anna Schmitt, Maria Carolina Romero Carrasco, Michaela Ihle, Stephanie Hampp, Dietrich Alexander Ruess, Elisabeth Heßmann, Ronan Russell, André Lechel, Ninel Azoitei et al. · 2017 · Cancer Research
A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis
Kaitlin J. Basham, Stéphanie Rodriguez, Adina F. Turcu, Antônio Marcondes Lerário, Catriona Y. Logan, Madeline R. Rysztak, Celso E. Gómez-Sánchez, David T. Breault, Bon‐Kyoung Koo, Hans C. Clevers et al. · 2019 · Genes & Development
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
Saswati N. Chand, Kevin O’Hayer, Fernando F. Blanco, Jordan Michael Winter, Jonathan Robert Brody · 2016 · International Journal of Biological Sciences
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression
Yann Wallez, Charles R. Dunlop, Timothy Isaac Johnson, Siang‐Boon Koh, Chiara Fornari, James W.T. Yates, Sandra Bernaldo de Quirós Fernández, Alan Lau, Frances M. Richards, Duncan Ian Jodrell · 2018 · Molecular Cancer Therapeutics
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
Marin Strijker, Eline C. Soer, Matteo De Pastena, Aafke Creemers, Alberto Balduzzi, Jamie J. Beagan, Olivier R. Busch, Otto M. van Delden, Hans Halfwerk, Jeanin Elise van Hooft et al. · 2019 · International Journal of Cancer
Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
Negesse Mekonnen, Hobin Yang, Young Kee Shin · 2022 · Frontiers in Oncology
Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
Erik S. Knudsen, Eileen Mary O'Reilly, Jonathan Robert Brody, Agnieszka Katarzyna Witkiewicz · 2015 · Gastroenterology
Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
MichaelP Kim, Yun Zhang, Guillermina Lozano · 2015 · Frontiers in Oncology
Therapeutic Cancer Vaccines
Jeffrey Schlom, James W. Hodge, Claudia Palena, Kwong-Yok Tsang, Caroline Jochéms, John W. Greiner, Benedetto Farsaci, Ravi Amrit Madan, Christopher Ryan Heery, James L. Gulley · 2014 · Advances in cancer research
Targeting KRAS in pancreatic cancer: new drugs on the horizon
Sahar F. Bannoura, Md. Hafiz Uddin, Misako Nagasaka, Farzeen Fazili, Mohammed Najeeb Al Hallak, Philip A. Philip, Bassel F. El‐Rayes, Asfar Sohail Azmi · 2021 · Cancer and Metastasis Reviews
Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma
Joshua B.N. Dawkins, Jun Wang, Eleni Maniati, James A. Heward, Lola Koniali, Hemant Mahendrakumar Kocher, Sarah A. Martin, Claude Chelala, Frances R. Balkwill, Jude Fitzgibbon et al. · 2016 · Cancer Research
Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers
Masaru Katoh · 2019 · Clinical Science
Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
Gwen Alyce Lomberk, Nelson Dusetti, Juan Iovanna, Raul A. Urrutia · 2019 · Nature Communications
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program
Michael Jon Pishvaian, Edik Matthew Blais, Jonathan Robert Brody, Lola Rahib, Emily E. Lyons, Patricia Arbeloa, Andrew Eugene Hendifar, Sameh Mikhail, Vincent M. Chung, Davendra P. S. Sohal et al. · 2019 · JCO Precision Oncology
Tumor Heterogeneity in Pancreatic Adenocarcinoma
Jerome F. Cros, Jérôme Raffenne, Anne Couvelard, Nicolas Poté · 2017 · Pathobiology
Current Insights of BRAF Inhibitors in Cancer
Bogos Agianian, Evripidis Gavathiotis · 2018 · Journal of Medicinal Chemistry
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
Stefanie Bärthel, Chiara Falcomatà, Roland Rad, Fabian Joachim Theis, Dieter Saur · 2023 · Nature Cancer
Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility
Erik S. Knudsen, Uthra Balaji, Brian K. Mannakee, Paris J. Vail, Cody R. Eslinger, Christopher Moxom, John C. Mansour, Agnieszka Katarzyna Witkiewicz · 2017 · Gut
NARCA: A novel prognostic scoring system using neutrophil‐albumin ratio and Ca19‐9 to predict overall survival in palliative pancreatic cancer
Samuel James Tingle, George R. Severs, Michael Goodfellow, John A. G. Moir, Steven Alan White · 2018 · Journal of Surgical Oncology
Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling
Marialetizia Motta, Miray Fidan, Emanuele Bellacchio, Francesca Pantaleoni, Konstantin Schneider‐Heieck, Simona Coppola, Guntram Borck, Leonardo Salviati, Martin Zenker, Ion Cristian Cirstea et al. · 2018 · Human Molecular Genetics
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Alexander Biederstädt, Zonera Hassan, Christian Schneeweis, Markus Schick, Lara Schneider, Alexander Muckenhuber, Ying‐Fen Hong, Gerrit Siegers, Lisa M. Nilsson, Matthias Wirth et al. · 2020 · Gut
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
Musalula Sinkala, Nicola Mulder, Darren Patrick Martin · 2020 · Scientific Reports
Systemic treatment of pancreatic cancer revisited
Michel Pierre Ducreux, Thomas Theodor Werner Seufferlein, Jean–Luc Van Laethem, Pierre Laurent‐Puig, Cristina Smolenschi, David Malka, Valérie Boige, Antoine Hollebecque, Thierry Conroy · 2018 · Seminars in Oncology
Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer
Vidhi M. Shah, Brett C. Sheppard, Rosalie C. Sears, Adam W. G. Alani · 2020 · Cancer Letters
USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
Hou, Pingping, Ma, Xingdi, Zhang, Qiang, Wu, Chang-Jiun, Liao, Wenting, Li, Jun, Wang, Huamin, Zhao, Jun, Zhou, Xin, Guan, Carolyn et al. · 2019 · Genes & Development
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
Sreenivasa Rao Chandana, Hani M. Babiker, Daruka Mahadevan · 2018 · Expert Opinion on Investigational Drugs
Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
Fumiaki Watanabe, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Yuji Takayama, Hideki Ishikawa, Nao Kakizawa, Masaaki Saito, Kazushige Futsuhara et al. · 2019 · PLoS ONE
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
James R. W. Conway, David Herrmann, TR Jeffry Evans, Jennifer P. Morton, Paul Timpson · 2018 · Gut
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner
Vivek Kumar Mishra, Florian Wegwitz, Robyn Laura Kosinsky, Madhobi Sen, Roland Baumgartner, Tanja Wulff, Jens Thomas Siveke, Hans‐Ulrich Schildhaus, Zeynab Najafova, Vijayalakshmi Kari et al. · 2017 · Nucleic Acids Research
Genetic Alterations of TRAF Proteins in Human Cancers
Sining Zhu, Juan Jin, Samantha Gokhale, Angeli M. Lu, Haiyan Shan, Jian‐Jun Feng, Ping Xie · 2018 · Frontiers in Immunology
Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes
Premila Devi Leiphrakpam, Sanjib Chowdhury, Michelle H. Zhang, Varnica Bajaj, Mashaal Dhir, Chandrakanth Are · 2025 · Journal of Gastrointestinal Cancer
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer
Agnieszka Katarzyna Witkiewicz, Uthra Balaji, Cody R. Eslinger, Elizabeth A. McMillan, William Charles Conway, Bruce A. Posner, Gordon Brent Mills, Eileen Mary O'Reilly, Erik S. Knudsen · 2016 · Cell Reports
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas
Andreas Wolfgang Berger, Daniel Schwerdel, Ivan G. Costa, Thilo Hackert, Oliver Strobel, Sandra Lam, Thomas F.E. Barth, Bernd Schröppel, Alexander G. Meining, Markus Wolfgang Büchler et al. · 2016 · Gastroenterology
From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions
Catherine G. Fischer, Laura DeLong Wood · 2018 · The Journal of Pathology
Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic <i>KLF4</i> mutations predominantly in low-grade regions
Fujikura, Kohei, Hosoda, Waki, Felsenstein, Matthäus, Song, Qianqian, Reiter, Johannes G, Zheng, Lily, Beleva Guthrie, Violeta, Rincon, Natalia, Dal Molin, Marco, Dudley, Jonathan et al. · 2021 · Gut
Genetics of familial and sporadic pancreatic cancer
Wood, Laura D., Yurgelun, Matthew B., Goggins, Michael G. · 2019 · Gastroenterology
SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation
Catherine C. Fahey, Ian J. Davis · 2017 · Cold Spring Harbor Perspectives in Medicine
ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice
Kimura, Yoshito, Fukuda, Akihisa, Ogawa, Satoshi, Maruno, Takahisa, Takada, Yutaka, Tsuda, Motoyuki, Hiramatsu, Yukiko, Araki, Osamu, Nagao, Munemasa, Yoshikawa, Takaaki et al. · 2018 · Gastroenterology
Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing
Jiawei Zhao, Yue Sun, Yin Huang, Fan Song, Zengshu Huang, Yufang Bao, Ji Zuo, David W. Saffen, Zhen Shao, Wen Liu et al. · 2017 · Scientific Reports
Sequential Targeting TGF‐β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer
Yuanyuan Pei, Chen Liang, Yukun Huang, Jiahao Wang, Jingxian Feng, Minjun Xu, Yu Chen, Qingxiang Song, Gan Jiang, Xiao Qin Gu et al. · 2019 · Small
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer
Christina R Adams, Htet Htwe Htwe, Timothy Marsh, Aprilgate L Wang, Megan L. Montoya, Lakshmipriya Subbaraj, Aaron D. Tward, Nabeel M. Bardeesy, Rushika M. Perera · 2019 · eLife
Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer
Hayashi, Hideyuki, Kohno, Takashi, Ueno, Hideki, Hiraoka, Nobuyoshi, Kondo, Shunsuke, Saito, Motonobu, Shimada, Yoko, Ichikawa, Hitoshi, Kato, Mamoru, Shibata, Tatsuhiro et al. · 2017 · Pancreas
Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies
Tessa Y. S. Le Large, Maarten F. Bijlsma, Geert Kazemier M, Hanneke W.M. van Laarhoven, Elisa Giovannetti, Connie R. Jiménez · 2017 · Seminars in Cancer Biology
ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas.
Wenjia Wang, Scott C. Friedland, B. Guo, Michael R. O'Dell, William B. Alexander, Christa L. Whitney-Miller, Diana Agostini-Vulaj, Aaron R. Huber, Jason R. Myers, J. Ashton et al. · 2018 · Gut
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead
Minela Aslan, Reza Shahbazi, Kezban Ulubayram, Bülent Özpolat · 2018 · Anticancer Research
Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation
Tim D.D. Somerville, Giulia Biffi, Juliane Daßler‐Plenker, Stella K. Hur, Xue‐Yan He, Krysten E. Vance, Koji Miyabayashi, Yali Xu, Diogo Maia-Silva, Olaf Klingbeil et al. · 2020 · eLife
Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer
Xiaoyu Liu, Lingxiao Liu, Yuan Ji, Changyu Li, Tao Wei, Xuerong Yang, Yuefang Zhang, Xuyu Cai, Ting Yang, Yangbin Gao et al. · 2019 · EBioMedicine
Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models
Gang Yang, Wenfang Guan, Zhe Cao, Wenbo Guo, Guangbing Xiong, Fangyu Zhao, Mengyu Feng, Jiangdong Qiu, Yueze Liu, Michael Q. Zhang et al. · 2021 · Clinical Cancer Research
Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia–mesenchymal transition during pancreatic carcinogenesis
Ningning Niu, Ping Lu, Yan-Lin Yang, Ruizhe He, Li Zhang, Juanjuan Shi, Jinghua Wu, Minwei Yang, Zhigang Zhang, Liwei Wang et al. · 2019 · Gut
Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
Wenjie Huang, Bernat Navarro-Serer, Yea Ji Jeong, Peter E. Chianchiano, Limin Xia, Claudio Luchini, Nicola Veronese, Cameron Dowiak, Tammy Ng, María Aurora Martínez Trujillo et al. · 2020 · Cancer Research
Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer
Lucia Roa‐Peña, Cindy V. Leiton, Sruthi Babu, Chun‐Hao Pan, Elizabeth A. Vanner, Ali Akalin, Jela Bandovic, Richard A. Moffitt, Kenneth Reed Shroyer, Luisa F. Escobar‐Hoyos · 2019 · Scientific Reports
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
Charles Li, Elena Bonazzoli, Stefania Bellone, Jungmin Choi, Weilai Dong, Gulden Menderes, Gary H. Altwerger, Chanhee Han, Aránzazu Manzano, Anna Bianchi et al. · 2018 · Proceedings of the National Academy of Sciences
Targeted Therapies for Pancreatic Cancer
Idoroenyi Usua Amanam, Vincent M. Chung · 2018 · Cancers
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia
Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian F. Stahl, Simon J. Hogg, Jan Philipp Bewersdorf, Cuijuan Han, Michael Singer et al. · 2022 · Cancer Cell
A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS
Xiaohua Duan, Tuo Zhang, Lingling Feng, Neranjan de Silva, Benjamin C. Greenspun, Xing Wang, Jenna E. Moyer, M. Laura Martin, Rohit Chandwani, Olivier Elemento et al. · 2023 · Cell stem cell
Concepts to Target MYC in Pancreatic Cancer
Matthias Wirth, Siavosh Mahboobi, Oliver Holger Krämer, Günter Schneider · 2016 · Molecular Cancer Therapeutics
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
Makoto Sugimori, Kazuya Sugimori, Hiromi Tsuchiya, Yoshimasa Suzuki, Sho Tsuyuki, Yoshihiro Kaneta, Akane Hirotani, Katsuyuki Sanga, Yuichiro Tozuka, Satoshi Komiyama et al. · 2019 · Cancer Science
Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer
Erik S. Knudsen, Vishnu Muthuraj Kumarasamy, Sejin Chung, Amanda Ruiz, Paris J. Vail, Stephanie L. Tzetzo, Jin Wu, Ram Nambiar, Jared Sivinski, Shailender Singh Chauhan et al. · 2020 · Gut
Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy
Despina Siolas, Emily Vucic, Emma Kurz, Cristina H Hajdu, Dafna Bar‐Sagi · 2020 · Cell Reports
Molecular impact of mutations in RNA splicing factors in cancer
Qian Zhang, Yuxi Ai, Omar Ibrahim Abdel-Wahab · 2024 · Molecular Cell
Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems
Frederike Dijk, Veronique L. Veenstra, Eline C. Soer, Mark P.G. Dings, Lan Zhao, Johannes B.G. Halfwerk, Gerrit K. J. Hooijer, Helene Damhofer, Marco Marzano, Anne Steins et al. · 2020 · Scientific Reports
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
Christian Hirt, Tijmen H. Booij, Linda Grob, Patrik Simmler, Nora C. Toussaint, David Keller, Doreen Taube, Vanessa Ludwig, Alexander Goryachkin, Chantal Pauli et al. · 2022 · Cell Genomics
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma
Daniel Schaefer, Stefan Tomiuk, Laura Nadine Kuester, Wa’el Al Rawashdeh, Janina Henze, German Tischler-Höhle, David Agorku, Janina Brauner, Cathrin Linnartz, Dominik Lock et al. · 2021 · Nature Communications
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
Allen-Petersen, Brittany L., Risom, Tyler, Feng, Zipei, Wang, Zhiping, Jenny, Zina P., Thoma, Mary C., Pelz, Katherine R., Morton, Jennifer P., Sansom, Owen J., Lopez, Charles D. et al. · 2019 · Cancer Research
Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells
Kei Takahashi, Shogo Ehata, Daizo Koinuma, Yasuyuki Morishita, Manabu Soda, Hiroyuki Mano, Kohei Miyazono · 2018 · Oncogene
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications
Sandrina Martens, Pierre Lefesvre, Rémy Nicolle, Andrew Victor Biankin, Francesco Puleo, Jean‐Luc Van Laethem, Ilse Rooman · 2019 · Annals of Oncology
Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer
Irina Heid, Katja Steiger, Marija Trajkovic‐Arsic, Marcus Settles, Manuela R. Eßwein, Mert Erkan, Jorg H. Kleeff, Carsten Jäger, Helmut Friess, Bernhard Haller et al. · 2016 · Clinical Cancer Research
CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing
Yuchao Jiang, Rujin Wang, Eugene Urrutia, Ioannis N. Anastopoulos, Katherine L. Nathanson, Nancy Ruonan Zhang · 2018 · Genome biology
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
Caitlin A. McIntyre, Sharon Lawrence, Allison L. Richards, Joanne F. Chou, Winston Wong, Marinela Capanu, Michael F. Berger, Mark T.A. Donoghue, Kenneth H. Yu, Anna M. Varghese et al. · 2020 · Cancer
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
Michal Bassani‐Sternberg, Antonia Digklia, Florian Huber, Dorothea Wagner, Christine L Sempoux, Brian J. Stevenson, Anne‐Christine Thierry, Justine Michaux, HuiSong Pak, Julien Racle et al. · 2019 · Frontiers in Immunology
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications
Samantha Ann Armstrong, Christopher William Schultz, Ariana Azimi-Sadjadi, Jonathan Robert Brody, Michael Jon Pishvaian · 2019 · Molecular Cancer Therapeutics
THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer
Ping Lu, Jing Geng, Lei Zhang, Yu Wang, Ningning Niu, Yuan Fang, Fang Liu, Juanjuan Shi, Zhigang Zhang, Yongwei Sun et al. · 2019 · Oncogene
Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology
Cédric Leroux, Georgia Konstantinidou · 2021 · Cancers
Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer
Dhananjay Huilgol, Prabhadevi Venkataramani, Saikat Nandi, Sonali Bhattacharjee · 2019 · Genes
Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
Benjamin Bian, Martin Bigonnet, Odile Gayet, Céline Loncle, Aurélie Maignan, Marine Gilabert, Vincent Moutardier, Stéphane Garcia, Olivıer Turrini, Jean‐Robert Delpéro et al. · 2017 · EMBO Molecular Medicine
SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer
Gregory P. Botta, Shumei Kato, Hitendra Patel, Paul Timothy Fanta, Suzanna Lee, Ryosuke Okamura, Razelle Kurzrock · 2021 · JCI Insight
Mechanisms of PDAC subtype heterogeneity and therapy response
Elisa Espinet, Lukas Klein, Ellen Puré, Shiv K. Singh · 2022 · Trends in cancer
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
Michael Jon Pishvaian, R Joseph Bender, Lynn McCormick Matrisian, Lola Rahib, Andrew Eugene Hendifar, William Arthur Hoos, Sam Mikhail, Vincent M. Chung, Vincent J. Picozzi, Craig Heartwell et al. · 2016 · Oncotarget
Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
Miles W. Grunvald, Richard A. Jacobson, Timothy Michael Kuzel, Sam G. Pappas, Ashiq Masood · 2020 · International Journal of Molecular Sciences
Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis
Aafke Creemers, Sarah Krausz, Marin Strijker, Myrtle J. van der Wel, Eline C. Soer, Roy J.A. Reinten, Marc G. Besselink, Johanna W. Wilmink, Marc J. van de Vijver, Carel J.M. van Noesel et al. · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Rajbhandari, Nirakar, Lin, Wan-chi, Wehde, Barbara L., Triplett, Aleata A., Wagner, Kay-Uwe · 2017 · Cell Reports
APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis
Sonja M. Wörmann, Amy Xin Wei Zhang, Fredrik I. Thege, Robert W. Cowan, Dhwani N. Rupani, Runsheng Wang, Sara L. Manning, Chris Gates, Wei-Sheng Wu, Rena Levin-Klein et al. · 2021 · Nature Cancer